MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
12.70
+0.31
+2.46%
Opening 13:49 08/21 EDT
OPEN
12.57
PREV CLOSE
12.39
HIGH
12.82
LOW
12.52
VOLUME
243.80K
TURNOVER
--
52 WEEK HIGH
53.55
52 WEEK LOW
9.40
MARKET CAP
217.73M
P/E (TTM)
-0.9825
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharma Names CEO Seth Lederman Interim CMO
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Tonix Pharma (TNXP)
TipRanks · 3d ago
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
The Motley Fool · 4d ago
Weekly Report: what happened at TNXP last week (0810-0814)?
Weekly Report · 4d ago
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Simply Wall St · 08/13 11:31
Tonix Pharmaceuticals (TNXP) Revenue Surge Meets Persistent Cash Burn Concerns
Simply Wall St · 08/12 02:40
Tonix Pharma Q2 Net Product Revenue Jumps On TONMYA Sales; Multiple Clinical Catalysts Ahead
NASDAQ · 08/11 11:41
Tonix Delivers A Beat, But The Real Test Starts Now
Seeking Alpha · 08/11 10:53
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.